Skip to content

PharmA-B-C

Active Private limited companyfounded 2014active for 12 yearsRue de l'Eglise 8, 1410 WaterlooKBO/BCE: BE 0563.344.722

Lifetime

11 annual accounts with figures on one time axis
peak of €86,424 in 2020
€36,120▲ 17.6%
lowest -€31,432 in 2019
€1,873▲ 14.2%
peak of €32,006 in 2018
-€18,129▲ €1,873
€204,788▲ 20.1%
Board2 names since 2014
- 
Documentsfilings and deeds
30-08-202630 days late
2025micro format
Gross margin from €30,713 to €36,120Debts from €170,480 to €204,788Cash from €36,169 to €83,766

Key points

from the 2025 annual accounts

Equity

-€18,129
202020212022202320242025

Debts exceed assets in financial year 2025.

Debts

€204,788 110% of the balance sheet
Suppliers 2%Taxes and wages 8%Other 90%

Position in the sector

-€18,129

Less equity than 92% of companies in advertising and market research. The sector median is €59,355, over 9,149 companies.

2025 accounts filed 30 days after the deadline

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 1,380 companies had the same profile as PharmA-B-C has now. Each dot stands for 4 companies, two years later.

94.1%
were still trading
3.3%
stopped another way
2.4%
went bankrupt
  • Micro
  • 10 to 20 years old
  • negative equity
  • a profit under 5% of the balance sheet

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 1,380 companies, not a prediction for PharmA-B-C. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

last known board
Director, last mentioned in 2019
  • 171 sharesdeed of 27-11-2019
  • 15 sharesdeed of 27-11-2019
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0563344722
changes role from manager to director holds 171 shares · holds 15 shares · Legal-form conversion: from private limited company (pre-2019) to private limited company · General meeting of 25-11-2019 · Gazette deed
First establishment Rue de l'Eglise 8, Waterloo
Incorporation Founding capital of €18,600, 186 shares · Founded by and · appointed as manager · published on 30-09-2014 · Gazette deed
All 20 events

Comparable companies

same main activity, similar in size and age
Company
PharmA-B-C Waterloo €186,659 €36,120 -9.7% -
DSFY Lasne €181,455 €38,396 52.2% -
3Pom Chaumont-Gistoux €203,930 €43,350 11.1% -
Demets Taal & Media Hoogstraten €192,210 €40,559 91.9% -
VISION & VALUES Etterbeek €176,053 €36,920 51.5% -
CORNFIELDS Mechelen €180,045 €36,942 94.1% -
BusinessInteractions Antwerp €197,808 €42,131 93.1% -

These companies have the same main activity as PharmA-B-C: public relations and communication consultancy (NACE 73300). They are comparable in size and age: total assets between €176,000 and €204,000, founded between 2013 and 2015.

Official details

Source: KBO
Status
Active since 26-09-2014Normal situation
Activity
Public relations and communication consultancyNACE 73300and 1 other
Establishment unit
2.235.305.4141410 Waterloo, since 15-10-2014
Financial year end
31 December
Peppol
Reachable since 21-05-2025
Company details

Annual accounts 2025

≈ €100,000estimated
€186,659▲ 24.0%
Filing
Filed on 30-08-2026
Financials

Insights on PharmA-B-C

PharmA-B-C files the micro format. That format states no turnover. The gross margin rose from €18,161 in 2015 to €36,120 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about PharmA-B-C

What is the company number of PharmA-B-C?
The company number of PharmA-B-C is 0563.344.722. The VAT number is the same number with BE in front: BE 0563.344.722.
Where is PharmA-B-C based?
The registered office is at Rue de l'Eglise 8, 1410 Waterloo.Company details
What does PharmA-B-C do?
According to the KBO register, the main activity is public relations and communication consultancy (NACE 73300).
What is the legal form of PharmA-B-C?
PharmA-B-C is a private limited company (BV).
When was PharmA-B-C founded?
PharmA-B-C was founded on 26-09-2014.
Is PharmA-B-C still active?
Yes, PharmA-B-C is an active enterprise in the KBO register.
What is the turnover of PharmA-B-C?
The turnover in financial year 2025 is about €100,000. This figure is estimated from the gross margin of €36,120 and 35 comparable companies (NACE 73). It probably lies between €72,000 and €140,000.Financials
Is PharmA-B-C profitable?
In financial year 2025, PharmA-B-C made a profit of €1,873.
Where can I find the annual accounts of PharmA-B-C?
PharmA-B-C filed 11 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PharmA-B-C due?
PharmA-B-C must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.